Xconomy: John Maraganore News, Articles and Opinions

“john-maraganore” Archives

Entry	Author	Date	Location
To Fight Cramps, Christoph Westphal Taps Boston All-Stars for $40M	Ben Fidler	09/09/14	Boston
John Maraganore: From “Prototypical Geek” To Canny Alnylam Chief	Ben Fidler	09/07/14	Boston
7 Takeaways From “What’s Hot in Boston Biotech”	Ben Fidler	04/22/14	Boston
What’s Hot in Boston Biotech: Here’s the Agenda for April 16	Ben Fidler	03/27/14	Boston
Hunting For Brain Plaques, Neurophage Turns to a Virus	Ben Fidler	01/31/14	Boston
Moderna, Living a Charmed Life, Pulls in Another $125M From Alexion	Luke Timmerman	01/13/14	Boston
Alnylam Wheels, Deals, and Gets $700M Investment From Genzyme	Ben Fidler	01/13/14	Boston
Arrowhead Picks Up Where Roche Left Off, Jumps Ahead in RNAi	Luke Timmerman	12/20/13	Wisconsin
21 Red Flags to Watch for in a Biotech Company	Luke Timmerman	10/21/13	National
Alnylam Shares Boom on Early Data For Subcutaneous RNA Drug	Ben Fidler	07/11/13	Boston
Alnylam Gets $25M From Medicines Co. for Cholesterol Drug	Luke Timmerman	02/04/13	Boston
Alnylam, Tekmira Look Ahead After RNAi Divorce	Luke Timmerman	11/14/12	Boston
Alnylam to Pay Tekmira $65M to Settle RNAi Delivery Dispute	Luke Timmerman	11/12/12	Boston
Brace Yourself: Biotech IPOs Are Beating Tech’s Big Names	Luke Timmerman	08/13/12	National
Alnylam Stock Climbs on Positive Early Trial for Amyloidosis	Luke Timmerman	07/16/12	Boston
Join Us for BIO Tweetchat at 12:30 pm ET with John Maraganore	Luke Timmerman	06/15/12	National
AIDS Drugs Were the Start. Let’s See More FDA Accelerated Approvals	Luke Timmerman	03/12/12	National
Reinventing Biotech: Meet Corey Goodman, Kevin Starr & More April 3	Luke Timmerman	02/23/12	Seattle
Join Kevin Starr, Corey Goodman, Carl Weissman & More in Seattle April 3	Luke Timmerman	01/19/12	Seattle
Biology 101	John Maraganore	01/18/12	Boston
Alnylam Racing to Prove RNAi Works, For a Disease You’ve Never Heard Of	Luke Timmerman	12/13/11	Boston
Alnylam and Glaxo Partner on RNAi for Vaccine Production	Arlene Weintraub	11/01/11	Boston
Celgene Pays Agios $20M, Lycera Adds Cambridge CEO, Getinge Buys Atrium Medical, & More Boston-Area Life Sciences News	Erin Kutz	10/07/11	Boston
Light Sciences Stumbles, Cardiac Dimensions Gets EU OK, Immune Design Pockets $11M, & More Seattle-Area Life Sciences News	Luke Timmerman	10/06/11	Seattle
Tweetchat on RNA Interference Upstages iPhone (Not Really, but It Was Still Fun)	Luke Timmerman	10/05/11	National
Join Us at 1 pm Eastern/10 am Pacific for RNAi “Tweetchat” with Alnylam’s John Maraganore	Luke Timmerman	10/04/11	National
UW Scores $40M for Biofuels, Cocrystal’s Fight Against HepC, The Women’s Biotech Network, & More Seattle-Area Life Sciences News	Luke Timmerman	09/29/11	Seattle
Join Us for a Live ‘Tweetchat’ on the Future of RNAi, With Guest John Maraganore of Alnylam	Luke Timmerman	09/28/11	National
Stirring the Pot Once in a While Doesn’t Hurt, and It Could Help Biotech Break its Malaise	Luke Timmerman	09/19/11	National
Cerulean Shows Progress in Cancer, Tests Nano-Drug Platform in RNAi	Arlene Weintraub	07/27/11	Boston
Page 2 of 5	« previous page · next page »